EUVIMEDEUVIMED entdecken
Crossref

Aptamer‐Assisted Blockade of the Immune Suppressor Sialic Acid‐Binding Immunoglobulin‐Like Lectin‐15 for Cancer Immunotherapy

Qiuyue Wu, Xinyu Wei, Fude Chen, Mengjiao Huang, Suhui Zhang, Lin Zhu, Leiji Zhou, Chaoyong Yang, Yanling Song iD

Angewandte Chemie International Edition · 2023

DOI: 10.1002/anie.202312609 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2023. Verfasst von Qiuyue Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Physical Chemistry of Solid Surfaces, Key Laboratory for Chemical Biology of Fujian Province, The MOE Key Laboratory of Spect…. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: the National Natural Science Foundation of China, Ministry of Science and Technology of China, the Program for Changjiang Scholars and Innovative Research Team in University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The percentage of low response and adaptive resistance to current antibody‐based immune checkpoint blockade (ICB) therapy requires the development of novel immunotherapy strategies. Here, we developed an aptamer‐assisted immune checkpoint blockade (Ap‐ICB) against sialic acid‐binding immunoglobulin‐like lectin‐15 (Siglec‐15), a novel immune suppressor broadly upregulated on cancer cells and tumor infiltrating myeloid cells, which is mutually exclusive of programmed cell death ligand 1 (PD‐L1). Using protein aptamer selection, we identified WXY3 aptamer with high affinity against Siglec‐15 protein/Siglec‐15 positive cells. We demonstrated that WXY3 aptamer rescued antigen‐specific T cell responses in vitro and in vivo. Importantly, the WXY3 Ap‐ICB against Siglec‐15 amplified anti‐tumor immunity in the tumor microenvironment and inhibited tumor growth/metastasis in syngeneic mouse model, which may result from enhanced macrophage and T cell functionality. In addition, by using aptamer‐based spherical nucleic acids, we developed a synergetic ICB strategy of multivalent binding and steric hindrance, which further improves the in vivo anti‐tumor effect. Taken together, our results support Ap‐ICB targeted Siglec‐15 as a potential strategy for normalization cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsNeoplasmsMiceAnimalsImmunotherapyImmunoglobulinsSialic Acid Binding Immunoglobulin-like LectinsSialic AcidsTumor MicroenvironmentMembrane Proteins

Stichwörter der Autor:innen

AptamerCancer ImmunotherapySiglec-15Spherical Nucleic Acids

Substanzen

Immune Checkpoint InhibitorsImmunoglobulinsSialic Acid Binding Immunoglobulin-like LectinsSialic AcidsSiglec-15 protein, mouseMembrane Proteins

Autor:innen und Institutionen

  • State Key Laboratory of Physical Chemistry of Solid Surfaces, Key Laboratory for Chemical Biology of Fujian Province, The MOE Key Laboratory of Spectrochemical Analysis & Instrumentation, Department of Chemical Biology,…
  • Institute of Molecular Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 200127, Shanghai, China.

ORCID-Profile: Yanling Song

Förderung

  • the National Natural Science Foundation of China
  • Ministry of Science and Technology of China
  • the Program for Changjiang Scholars and Innovative Research Team in University

Zitieren

APA

Wu, Q., Wei, X., Chen, F., Huang, M., Zhang, S., Zhu, L., Zhou, L., Yang, C., & Song, Y. (2023). Aptamer‐Assisted Blockade of the Immune Suppressor Sialic Acid‐Binding Immunoglobulin‐Like Lectin‐15 for Cancer Immunotherapy. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202312609

Vancouver

Wu Q, Wei X, Chen F, Huang M, Zhang S, Zhu L, et al. Aptamer‐Assisted Blockade of the Immune Suppressor Sialic Acid‐Binding Immunoglobulin‐Like Lectin‐15 for Cancer Immunotherapy. Angewandte Chemie International Edition. 2023. doi:10.1002/anie.202312609

BibTeX
@article{Wu2023,
  author = {Wu, Qiuyue and Wei, Xinyu and Chen, Fude and Huang, Mengjiao and Zhang, Suhui and Zhu, Lin and Zhou, Leiji and Yang, Chaoyong and Song, Yanling},
  title = {Aptamer‐Assisted Blockade of the Immune Suppressor Sialic Acid‐Binding Immunoglobulin‐Like Lectin‐15 for Cancer Immunotherapy},
  journal = {Angewandte Chemie International Edition},
  year = {2023},
  doi = {10.1002/anie.202312609}
}
Kostenlos starten →